Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Researchers identify bone-forming cells as the driver of scoliosis caused by a genetic disorder, which can be prevented ...

V2X, Inc., , a leading provider of global mission solutions, will report fourth quarter and full year 2025 financial results on Monday, February 23, 2026, after market close. Senior management will ...

"The death of American patriotism appears to have been greatly exaggerated," says political scientist Dr. John West, author of the new report How Americans View the American Founding. "Despite a ...

Erasca (ERAS) has surged 460% over the past year, driven by strong technical momentum. ERAS hit a new 3-year high of $10.92 on Monday. Despite bullish technicals, ERAS has no revenue, is burning cash, ...

New study reveals a central role of selenoprotein GPX3 in attenuating acute kidney injury Renal ischemia–reperfusion injury ...

The FDA approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), ...

Erasca Inc. (NASDAQ:ERAS) is one of the new stocks on the rise. On January 27, Guggenheim increased its price target for ...

Cancer is one of the causes responsible for the most deaths worldwide. In 2020, for example, it resulted in ten million ...

Echinacoside, or ECH, a naturally occurring compound derived from certain plants, eased the signs and symptoms of PAH in rats ...

How this fungus influences the development of melanoma cells has for the first time been explained by the MicrobiomicsEHU ...

Germany: Researchers have identified 1,557 blood-based epigenetic markers that can assess the risk of developing type 2 ...